Phase III RESOLVE trial of ibrutinib in metastatic pancreatic cancer misses primary endpoint Jan. 21, 2019
Phase III ANNOUNCE study of Lartruvo in soft tissue sarcoma does not meet primary endpoints Jan. 21, 2019
Canerpaturev plus standard chemotherapy shows encouraging antitumor activity in pancreatic cancer Jan. 21, 2019
Phase I results reported for galunisertib plus SBRT in advanced hepatocellular carcinoma Jan. 21, 2019
Preliminary phase Ib data presented for GLS-010 in patients with advanced gastrointestinal tumors Jan. 21, 2019
RSS